Citation: T. Mizuma et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION AND IDENTIFICATION OF ACYL MIGRATION AND PHOTODEGRADATION PRODUCTS OF FUROSEMIDE 1-O-ACYL GLUCURONIDE, Journal of chromatography B. Biomedical sciences and applications, 718(1), 1998, pp. 153-162
Citation: T. Mizuma et al., PREPARATIVE CHROMATOGRAPHY OF FUROSEMIDE 1-O-ACYL-GLUCURONIDE FROM URINE USING MICRONIZED AMBERIITE XAD-2 AND ITS APPLICATION TO OTHER 1-O-ACYL-GLUCURONIDES, Preparative biochemistry & biotechnology, 28(1), 1998, pp. 37-47
Citation: Yc. Zhang et Lz. Benet, CHARACTERIZATION OF P-GLYCOPROTEIN MEDIATED TRANSPORT OF K02, A NOVELVINYLSULFONE PEPTIDOMIMETIC CYSTEINE PROTEASE INHIBITOR, ACROSS MDR1-MDCK AND CACO-2 CELL MONOLAYERS, Pharmaceutical research, 15(10), 1998, pp. 1520-1524
Citation: K. Mohri et al., STEREOSELECTIVE METABOLISM OF BENOXAPROFEN IN RATS - BILIARY-EXCRETION OF BENOXAPROFEN TAURINE CONJUGATE AND GLUCURONIDE, Drug metabolism and disposition, 26(4), 1998, pp. 332-337
Citation: Yc. Zhang et al., OVERLAPPING SUBSTRATE SPECIFICITIES OF CYTOCHROME-P450 3A AND P-GLYCOPROTEIN FOR A NOVEL CYSTEINE PROTEASE INHIBITOR, Drug metabolism and disposition, 26(4), 1998, pp. 360-366
Citation: Y. Qiu et al., MECHANISMS FOR COVALENT BINDING OF BENOXAPROFEN GLUCURONIDE TO HUMAN SERUM-ALBUMIN - STUDIES BY TANDEM MASS-SPECTROMETRY, Drug metabolism and disposition, 26(3), 1998, pp. 246-256
Citation: Lz. Benet, IMPACT OF INTRAINDIVIDUAL VARIABILITY OF DRUGS ON THERAPEUTIC OUTCOMES - LESSONS FROM OUTSIDE TRANSPLANTATION, Transplantation proceedings, 30(5), 1998, pp. 1650-1651
Authors:
LAMPEN A
ZHANG YC
HACKBARTH I
FLOREN LC
BENET LZ
SEWING KF
CHRISTIANS U
Citation: A. Lampen et al., METABOLISM AND TRANSPORT OF THE MACROLIDE IMMUNOSUPPRESSANT SIROLIMUSIN THE SMALL-INTESTINE, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 1-1
Authors:
ZHANG YC
HSIEH YS
IZUMI T
LIN ET
BENET LZ
Citation: Yc. Zhang et al., EFFECTS OF KETOCONAZOLE ON THE INTESTINAL METABOLISM, TRANSPORT AND ORAL BIOAVAILABILITY OF K02, A NOVEL VINYLSULFONE PEPTIDOMIMETIC CYSTEINE PROTEASE INHIBITOR AND A P450 3A, P-GLYCOPROTEIN DUAL SUBSTRATE, INMALE SPRAGUE-DAWLEY RATS, The Journal of pharmacology and experimental therapeutics, 287(1), 1998, pp. 246-252
Authors:
LAMPEN A
ZHANG YC
HACKBARTH I
BENET LZ
SEWING KF
CHRISTIANS U
Citation: A. Lampen et al., METABOLISM AND TRANSPORT OF THE MACROLIDE IMMUNOSUPPRESSANT SIROLIMUSIN THE SMALL-INTESTINE, The Journal of pharmacology and experimental therapeutics, 285(3), 1998, pp. 1104-1112
Citation: Vj. Wacher et al., ROLE OF P-GLYCOPROTEIN AND CYTOCHROME-P450 3A IN LIMITING ORAL ABSORPTION OF PEPTIDES AND PEPTIDOMIMETICS, Journal of pharmaceutical sciences, 87(11), 1998, pp. 1322-1330
Citation: Yc. Qiu et al., IDENTIFICATION OF THE HEPATIC PROTEIN TARGETS OF REACTIVE METABOLITESOF ACETAMINOPHEN IN-VIVO IN MICE USING 2-DIMENSIONAL GEL-ELECTROPHORESIS AND MASS-SPECTROMETRY, The Journal of biological chemistry, 273(28), 1998, pp. 17940-17953
Citation: L. Salphati et Lz. Benet, MODULATION OF P-GLYCOPROTEIN EXPRESSION BY CYTOCHROME-P450 3A INDUCERS IN MALE AND FEMALE RAT LIVERS, Biochemical pharmacology, 55(4), 1998, pp. 387-395
Citation: St. Wu et al., STEREOSELECTIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY DETERMINATION OF PROPRANOLOL AND 4-HYDROXYPROPRANOLOL IN HUMAN PLASMA AFTER PRECOLUMN DERIVATIZATION, Journal of chromatography B. Biomedical sciences and applications, 692(1), 1997, pp. 133-140
Citation: St. Wu et al., DETERMINATION OF AMIPRILOSE IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUOROMETRIC DETECTION, Journal of chromatography B. Biomedical sciences and applications, 692(1), 1997, pp. 149-156
Citation: Gr. Jang et Lz. Benet, CYTOCHROME P4503A4-MEDIATIED N-DEMETHYLATION OF THE ANTIPROGESTINS LILOPRISTONE AND ONAPRISTONE, Drug metabolism and disposition, 25(10), 1997, pp. 1119-1122
Citation: Gr. Jang et Lz. Benet, ANTIPROGESTIN PHARMACODYNAMICS, PHARMACOKINETICS, AND METABOLISM - IMPLICATIONS FOR THEIR LONG-TERM USE, Journal of pharmacokinetics and biopharmaceutics, 25(6), 1997, pp. 647-672
Citation: R. Yuan et al., INVESTIGATION OF AORTIC CYP3A BIOACTIVATION OF NITROGLYCERIN IN-VIVO, The Journal of pharmacology and experimental therapeutics, 281(3), 1997, pp. 1499-1505
Authors:
LOWN KS
MAYO RR
LEICHTMAN AB
HSIAO HL
TURGEON DK
SCHMIEDLINREN P
BROWN MB
GUO WS
ROSSI SJ
BENET LZ
WATKINS PB
Citation: Ks. Lown et al., ROLE OF INTESTINAL P-GLYCOPROTEIN (MDR1) IN INTERPATIENT VARIATION INTHE ORAL BIOAVAILABILITY OF CYCLOSPORINE, Clinical pharmacology and therapeutics, 62(3), 1997, pp. 248-260
Authors:
FLOREN LC
BEKERSKY I
BENET LZ
MEKKI Q
DRESSLER D
LEE JW
ROBERTS JP
HEBERT MF
Citation: Lc. Floren et al., TACROLIMUS ORAL BIOAVAILABILITY DOUBLES WITH COADMINISTRATION OF KETOCONAZOLE, Clinical pharmacology and therapeutics, 62(1), 1997, pp. 41-49
Citation: Ai. Hajyehia et Lz. Benet, DETERMINATION OF ALCOHOLS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUOROMETRIC DETECTION AFTER PRECOLUMN DERIVATIZATION WITH 2-(4-CARBOXYPHENYL)-6-METHOXYBENZOFURAN, Journal of chromatography, 724(1-2), 1996, pp. 107-115
Authors:
SHAH VP
YACOBI A
BARR WH
BENET LZ
BREIMER D
DOBRINSKA MR
ENDRENYI L
FAIRWEATHER W
GILLESPIE W
GONZALEZ MA
HOOPER J
JACKSON A
LESKO LJ
MIDHA KK
NOONAN PK
PATNAIK R
WILLIAMS RL
Citation: Vp. Shah et al., EVALUATION OF ORALLY-ADMINISTERED HIGHLY VARIABLE DRUGS AND DRUG FORMULATIONS, Pharmaceutical research, 13(11), 1996, pp. 1590-1594